These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2782041)
1. Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Berr C; Puel J; Clanet M; Ruidavets JB; Mas JL; Alperovitch A Acta Neurol Scand; 1989 Jul; 80(1):46-50. PubMed ID: 2782041 [TBL] [Abstract][Full Text] [Related]
2. Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls. Alpérovitch A; Berr C; Cambon-Thomsen A; Puel J; Dugoujon JM; Ruidavets JB; Clanet M Hum Immunol; 1991 Jun; 31(2):94-9. PubMed ID: 2066275 [TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin allotypes and susceptibility to multiple sclerosis. An epidemiological and genetic study in the Hautes-Pyrénées county of France. Blanc M; Clanet M; Berr C; Dugoujon JM; Ruydavet B; Ducos SJ; Rascol A; Alpérovitch A J Neurol Sci; 1986 Aug; 75(1):1-5. PubMed ID: 3091773 [TBL] [Abstract][Full Text] [Related]
4. A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls. Haile R; Smith P; Read D; Nassim D; Warlow C; Russell WC J Neurol Sci; 1982 Oct; 56(1):1-10. PubMed ID: 7143023 [TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and common viral infections in Iceland. Gudmundsdóttir S Acta Pathol Microbiol Scand B; 1979 Dec; 87(6):379-84. PubMed ID: 539420 [TBL] [Abstract][Full Text] [Related]
6. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Compston DA; Vakarelis BN; Paul E; McDonald WI; Batchelor JR; Mims CA Brain; 1986 Apr; 109 ( Pt 2)(2):325-44. PubMed ID: 3456817 [TBL] [Abstract][Full Text] [Related]
7. Geographical Heterogeneity of Multiple Sclerosis Prevalence in France. Pivot D; Debouverie M; Grzebyk M; Brassat D; Clanet M; Clavelou P; Confavreux C; Edan G; Leray E; Moreau T; Vukusic S; Hédelin G; Guillemin F PLoS One; 2016; 11(12):e0167556. PubMed ID: 27936086 [TBL] [Abstract][Full Text] [Related]
8. Selective association of multiple sclerosis with infectious mononucleosis. Zaadstra BM; Chorus AM; van Buuren S; Kalsbeek H; van Noort JM Mult Scler; 2008 Apr; 14(3):307-13. PubMed ID: 18208871 [TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis. Cook SD; Dowling PC; Russell WC J Neurol Sci; 1979 Mar; 41(1):61-70. PubMed ID: 438844 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of viral antibodies in Iranian multiple sclerosis patients. Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611 [TBL] [Abstract][Full Text] [Related]
11. Common infectious agents in multiple sclerosis: a case-control study in children. Krone B; Pohl D; Rostasy K; Kahler E; Brunner E; Oeffner F; Grange JM; Gärtner J; Hanefeld F Mult Scler; 2008 Jan; 14(1):136-9. PubMed ID: 17942525 [TBL] [Abstract][Full Text] [Related]
12. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Ahlgren C; Torén K; Odén A; Andersen O Eur J Epidemiol; 2009; 24(9):541-52. PubMed ID: 19633994 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673 [TBL] [Abstract][Full Text] [Related]